Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 23092091 | HLA-B*27 | anterior uveitis | NA | NA | NA | unclassified | |
| the most frequent clinical entity was sarcoidosis (9.8%), followed by vogt-koyanagi-harada disease (7.9%), behcet's disease (7.6%), acute anterior uveitis associated with human leukocyte antigen (hla)-b27 (4.5%), herpetic iridocyclitis (3.1%), human t-lymphotropic virus type i associated uveitis (hu) (2.7%), and intraocular lymphoma (2.3%). | |||||||
| 23092091 | HLA-B*27 | vogt-koyanagi-harada disease | NA | NA | NA | unclassified | |
| the most frequent clinical entity was sarcoidosis (9.8%), followed by vogt-koyanagi-harada disease (7.9%), behcet's disease (7.6%), acute anterior uveitis associated with human leukocyte antigen (hla)-b27 (4.5%), herpetic iridocyclitis (3.1%), human t-lymphotropic virus type i associated uveitis (hu) (2.7%), and intraocular lymphoma (2.3%). | |||||||
| 23092091 | HLA-B*27 | sarcoidosis | NA | NA | NA | unclassified | |
| the most frequent clinical entity was sarcoidosis (9.8%), followed by vogt-koyanagi-harada disease (7.9%), behcet's disease (7.6%), acute anterior uveitis associated with human leukocyte antigen (hla)-b27 (4.5%), herpetic iridocyclitis (3.1%), human t-lymphotropic virus type i associated uveitis (hu) (2.7%), and intraocular lymphoma (2.3%). | |||||||
| 23092091 | HLA-B*27 | intraocular lymphoma | NA | NA | NA | unclassified | |
| the most frequent clinical entity was sarcoidosis (9.8%), followed by vogt-koyanagi-harada disease (7.9%), behcet's disease (7.6%), acute anterior uveitis associated with human leukocyte antigen (hla)-b27 (4.5%), herpetic iridocyclitis (3.1%), human t-lymphotropic virus type i associated uveitis (hu) (2.7%), and intraocular lymphoma (2.3%). | |||||||
| 23092091 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | iridocyclitis | NA | NA | NA | unclassified | |
| the most frequent clinical entity was sarcoidosis (9.8%), followed by vogt-koyanagi-harada disease (7.9%), behcet's disease (7.6%), acute anterior uveitis associated with human leukocyte antigen (hla)-b27 (4.5%), herpetic iridocyclitis (3.1%), human t-lymphotropic virus type i associated uveitis (hu) (2.7%), and intraocular lymphoma (2.3%). | |||||||
| 23092091 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | anterior uveitis | NA | NA | NA | unclassified | |
| the most frequent clinical entity was sarcoidosis (9.8%), followed by vogt-koyanagi-harada disease (7.9%), behcet's disease (7.6%), acute anterior uveitis associated with human leukocyte antigen (hla)-b27 (4.5%), herpetic iridocyclitis (3.1%), human t-lymphotropic virus type i associated uveitis (hu) (2.7%), and intraocular lymphoma (2.3%). | |||||||
| 23092091 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | vogt-koyanagi-harada disease | NA | NA | NA | unclassified | |
| the most frequent clinical entity was sarcoidosis (9.8%), followed by vogt-koyanagi-harada disease (7.9%), behcet's disease (7.6%), acute anterior uveitis associated with human leukocyte antigen (hla)-b27 (4.5%), herpetic iridocyclitis (3.1%), human t-lymphotropic virus type i associated uveitis (hu) (2.7%), and intraocular lymphoma (2.3%). | |||||||
| 23092091 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | sarcoidosis | NA | NA | NA | unclassified | |
| the most frequent clinical entity was sarcoidosis (9.8%), followed by vogt-koyanagi-harada disease (7.9%), behcet's disease (7.6%), acute anterior uveitis associated with human leukocyte antigen (hla)-b27 (4.5%), herpetic iridocyclitis (3.1%), human t-lymphotropic virus type i associated uveitis (hu) (2.7%), and intraocular lymphoma (2.3%). | |||||||
| 23092091 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | intraocular lymphoma | NA | NA | NA | unclassified | |
| the most frequent clinical entity was sarcoidosis (9.8%), followed by vogt-koyanagi-harada disease (7.9%), behcet's disease (7.6%), acute anterior uveitis associated with human leukocyte antigen (hla)-b27 (4.5%), herpetic iridocyclitis (3.1%), human t-lymphotropic virus type i associated uveitis (hu) (2.7%), and intraocular lymphoma (2.3%). | |||||||
| 26062391 | HLA-B*27 | iridocyclitis | NA | NA | NA | unclassified | |
| the most frequent clinical entity was sarcoidosis, followed by scleritis, vogt-koyanagi-harada disease, herpetic iridocyclitis without acute retinal necrosis, acute anterior uveitis associated with human leukocyte antigen (hla) -b27 and behcet's disease. | |||||||
Copyright 2024